ICB treatment was not significantly associated with tumor PD-L1 positivity (p > 0.99), presence of tumor MSI-high (p = 0.10), or presence of MMR deficiency (p = 0.43) (data not shown). Here, CD274 is linked to mismatch repair cancer syndrome 1.